Paget Disease of the Nipple Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Clinical Trials

Docosahexaenoic Acid in Preventing Recurrence in Breast Cancer Survivors
Conditions:   Ductal Breast Carcinoma in Situ;   Lobular Breast Carcinoma in Situ;   Paget Disease of the Breast;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast CancerInterventions:   Drug: docosahexaenoic acid;   Other: placebo;   Other: laboratory biomarker analysisSponsor:   National Cancer Institute (NCI)Recruiting - verified August 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2013 Category: Research Source Type: clinical trials

Docosahexaenoic Acid in Preventing Recurrence in Breast Cancer Survivors
Conditions:   Ductal Breast Carcinoma In Situ;   Lobular Breast Carcinoma In Situ;   Paget Disease of the Breast;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast CancerInterventions:   Drug: Docosahexaenoic Acid;   Other: Placebo;   Other: Laboratory Biomarker AnalysisSponsor:   National Cancer Institute (NCI)Recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2013 Category: Research Source Type: clinical trials

Docosahexaenoic Acid in Preventing Recurrence in Breast Cancer Survivors
Conditions:   Ductal Breast Carcinoma In Situ;   Lobular Breast Carcinoma In Situ;   Paget Disease of the Breast;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast CancerInterventions:   Drug: Docosahexaenoic Acid;   Other: Placebo;   Other: Laboratory Biomarker AnalysisSponsor:   National Cancer Institute (NCI)Recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2013 Category: Research Source Type: clinical trials

Docosahexaenoic Acid in Preventing Recurrence in Breast Cancer Survivors
Conditions:   Ductal Breast Carcinoma In Situ;   Lobular Breast Carcinoma In Situ;   Paget Disease of the Breast;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast CancerInterventions:   Drug: Docosahexaenoic Acid;   Other: Laboratory Biomarker Analysis;   Other: PlaceboSponsor:   National Cancer Institute (NCI)Recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2013 Category: Research Source Type: clinical trials